| scholarly article | Q13442814 |
| P50 | author | Qi Xie | Q88625346 |
| P2093 | author name string | Liming Liang | |
| Yin Li | |||
| Ran Xia | |||
| Cuiping Yang | |||
| Nuoyan Zheng | |||
| Huishan Guo | |||
| Bojiao Yin | |||
| Chengguo Duan | |||
| P2860 | cites work | Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats | Q24536078 |
| Severe acute respiratory syndrome coronavirus 7a accessory protein is a viral structural protein | Q24674321 | ||
| A combined nucleocapsid vaccine induces vigorous SARS-CD8+ T-cell immune responses | Q24816925 | ||
| Characterization of a novel coronavirus associated with severe acute respiratory syndrome | Q28202401 | ||
| Silencing on the spot. Induction and suppression of RNA silencing in the Agrobacterium-mediated transient expression system | Q28207040 | ||
| Bats are natural reservoirs of SARS-like coronaviruses | Q28274751 | ||
| A viral suppressor of gene silencing in plants | Q28286683 | ||
| Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants | Q28764574 | ||
| Retracted: An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus | Q29037949 | ||
| Cross-reactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11. | Q33226421 | ||
| Accumulation of recombinant SARS-CoV spike protein in plant cytosol and chloroplasts indicate potential for development of plant-derived oral vaccines | Q33256026 | ||
| Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice | Q33696283 | ||
| Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis | Q33843022 | ||
| An interferon-gamma-related cytokine storm in SARS patients | Q33844674 | ||
| Severe acute respiratory syndrome (SARS) S protein production in plants: development of recombinant vaccine | Q33863306 | ||
| RETRACTED: Viral pathogenicity determinants are suppressors of transgene silencing in Nicotiana benthamiana | Q33890067 | ||
| MicroRNA-binding viral protein interferes with Arabidopsis development | Q33900664 | ||
| Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms | Q33987404 | ||
| The SARS-CoV nucleocapsid protein: a protein with multifarious activities | Q34007055 | ||
| Severe acute respiratory syndrome coronavirus 3a protein is released in membranous structures from 3a protein-expressing cells and infected cells | Q34233067 | ||
| The Tombusvirus-encoded P19: from irrelevance to elegance | Q34499849 | ||
| Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. | Q34569888 | ||
| Expression of immunogenic S1 glycoprotein of infectious bronchitis virus in transgenic potatoes. | Q35182159 | ||
| The severe acute respiratory syndrome | Q35610030 | ||
| Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus | Q35857723 | ||
| SARS-CoV infection in a restaurant from palm civet | Q36009490 | ||
| Oral hepatitis B vaccine candidates produced and delivered in plant material | Q36118497 | ||
| Analysis of serum cytokines in patients with severe acute respiratory syndrome | Q36447254 | ||
| Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity | Q36449078 | ||
| Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease | Q36784740 | ||
| T cell responses to whole SARS coronavirus in humans | Q37195604 | ||
| Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus | Q37423250 | ||
| RNA silencing suppression by a second copy of the P1 serine protease of Cucumber vein yellowing ipomovirus, a member of the family Potyviridae that lacks the cysteine protease HCPro. | Q38761754 | ||
| The nucleocapsid protein of severe acute respiratory syndrome coronavirus inhibits cell cytokinesis and proliferation by interacting with translation elongation factor 1alpha | Q39763675 | ||
| Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV. | Q39926740 | ||
| Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses | Q40074291 | ||
| Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope | Q40107426 | ||
| Nucleocapsid protein of SARS-CoV activates interleukin-6 expression through cellular transcription factor NF-kappaB. | Q40134868 | ||
| The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles | Q40213197 | ||
| A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus. | Q40217209 | ||
| Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine | Q40506063 | ||
| Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids | Q40526248 | ||
| Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA. | Q40532995 | ||
| Characterization of N protein self-association in coronavirus ribonucleoprotein complexes | Q40610082 | ||
| Plant-made subunit vaccine against pneumonic and bubonic plague is orally immunogenic in mice | Q41455267 | ||
| Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine | Q43571642 | ||
| Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. | Q44805074 | ||
| Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in mice. | Q45262795 | ||
| Specific and efficient cleavage of fusion proteins by recombinant plum pox virus NIa protease | Q45399170 | ||
| The secret life of ACE2 as a receptor for the SARS virus | Q45704374 | ||
| Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses | Q45787560 | ||
| Differential characteristics of the early stage of lung inflammation induced by SARS-CoV Nucleocapsid protein related to age in the mouse | Q46113539 | ||
| Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates | Q46957936 | ||
| Profiles of IgG antibodies to nucleocapsid and spike proteins of the SARS-associated coronavirus in SARS patients | Q47745602 | ||
| Effects of a SARS-associated coronavirus vaccine in monkeys. | Q51639488 | ||
| Molecular farming and metabolic engineering promise a new generation of high-tech crops. | Q51705245 | ||
| Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients. | Q51982621 | ||
| Antigenic characterization of severe acute respiratory syndrome-coronavirus nucleocapsid protein expressed in insect cells: The effect of phosphorylation on immunoreactivity and specificity. | Q52679766 | ||
| [A study of pulmonary inflammatory reaction induced by N-protein of SARS-CoV in rat models and effects of glucocorticoids on it]. | Q53640965 | ||
| Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome | Q79276524 | ||
| [Validity and reliability of an instrument for predictive nursing intention for SARS patient care] | Q81481126 | ||
| P433 | issue | 36 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | viral nucleocapsid | Q4384107 |
| SARSr-CoV | Q278567 | ||
| SARS-CoV-1 | Q85438966 | ||
| P304 | page(s) | 5001-5007 | |
| P577 | publication date | 2009-06-11 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice. | |
| P478 | volume | 27 |
| Q30384772 | Antigen Production in Plant to Tackle Infectious Diseases Flare Up: The Case of SARS. |
| Q40922357 | Co-expression of hepatitis C virus polytope-HBsAg and p19-silencing suppressor protein in tobacco leaves. |
| Q34864615 | Enhanced-Transient Expression of Hepatitis C Virus Core Protein in Nicotiana tabacum, a Protein With Potential Clinical Applications. |
| Q30382230 | Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases. |
| Q26770021 | Nucleocapsid proteins: roles beyond viral RNA packaging |
| Q26783107 | Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agents |
| Q34325833 | Studying the RNA silencing pathway with the p19 protein |
| Q91711469 | Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses |
| Q37776717 | Transient expression systems for plant-derived biopharmaceuticals |
| Q64228969 | Transient plant production of Typhimurium diagnostic antibodies |
| Q98209615 | Vaccine development against coronavirus (2003 to present): An overview, recent advances, current scenario, opportunities and challenges |
| Q34774601 | Viral RNAi suppressor reversibly binds siRNA to outcompete Dicer and RISC via multiple turnover |
Search more.